Human cytochrome P450 maximal activities in pediatric versus adult liver

Drug Metabolism and Disposition

Volumn 28, Issue 4, 2000, Pages 379-382

  Blanco, Javier G ^a   Harrison, Patricia L ^a   Evans, William E ^a,b   Relling, Mary V ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ETHOXYCOUMARIN; ETHOXYRESORUFIN; MIDAZOLAM; PACLITAXEL; TENIPOSIDE; TOLBUTAMIDE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CATALYSIS; CHILD; DRUG CLEARANCE; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; INFANT; LIVER METABOLISM; OXIDATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGING; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; INFANT; INFANT, NEWBORN; ISOENZYMES; MICROSOMES, LIVER; MIDDLE AGED;

EID: 0034033851     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Brodie MJ, Boobis AR, Bulpitt CJ and Davies DS (1981) Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol 20:39-46.
2. Cazeneuve C, Pons G, Rey E, Treluyer JM, Cresteil T, Thiroux G, D'Athis P and Olive G (1994) Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults. Br J Clin Pharmacol 37:405-412.
3. Chandler MH, Scott SR and Blouin RA (1988) Age-associated stereoselective alterations in hexobarbital metabolism. Clin Pharmacol Ther 43:436-441.
4. Crom WR, Relling MV, Christensen ML, Rivera GK and Evans WE (1991) Age related differences in hepatic drug clearance in children: Studies with lorazepam and antipyrine. Clin Pharmacol Ther 50:132-140.
5. Curless RG, Walson PD and Carter DE (1976) Phenytoin kinetics in children. Neurology 26:715-720.
6. Dawling S and Crome P (1989) Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet 17:236-263.
7. Ellis EF, Koysooko R and Levy G (1976) Pharmacokinetics of theophylline in children with asthma. Pediatrics 58:542-547.
8. Evans RR and Relling MV (1992) Automated high-performance liquid chromatographic assay for the determination of 7-ethoxycoumarin and umbelliferone. J Chromatogr 578:141-145.
9. Evans WE, Relling MV, de Graaf S, Rodman JH, Pieper JA, Christensen ML and Crom WR (1989) Hepatic drug clearance in children: Studies with indocyanine green as a model substrate. J Pharmacol Exp Ther 78:452-456.
10. Evans WE, Sinkule JA, Crom WR, Dow L, Look T and Rivera G (1982) Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer. Cancer Chemother Pharmacol 7:147-150.
11. Kinirons MT and Crome P (1997) Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet 33:302-312.
12. Lacroix D, Sonnier M, Moncion A, Cheron G and Cresteil T (1997) Expression of CYP3A in the human liver-evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 147:625-634.
13. Le Couteur DG and McLean AJ (1998) The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 34:359-373.
14. Lubet RA, Mayer RT, Cameron JW, Nims RW, Burke MD, Wolff T and Guengerich FP (1985) Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys 238:43-48.
15. Miglioli PA, Pivetta P, Strazzabosco M, Orlando R, Okolicsanyi L and Palatini P (1990) Effect of age on single- and multiple-dose pharmacokinetics of erythromycin. Eur J Clin Pharmacol 39:161-164.
16. Murry DJ, Crom WR, Reddick WE, Bhargava R and Evans WE (1995) Liver volume as a determinant of drug clearance in children and adolescents. Drug Metab Dispos 23:1110-1116.
17. Noda T, Todani T, Watanabe Y and Yamamoto S (1997) Liver volume in children measured by computed tomography. Pediatr Radiol 27:250-252.
18. Relling MV, Aoyama T, Gonzalez FJ and Meyer UA (1990) Tolbutamide and mephenytoin hydroxylation by human cytochrome P450's in the CYP2C subfamily. J Pharmacol Exp Ther 252:442-447.
19. Relling MV, Evans R, Desiderio D, Dass C and Nemec J (1992) Human cytochrome P450 metabolism of teniposide and etoposide. J Pharmacol Exp Ther 261:491-496.
20. Relling MV, Nemec J, Schuetz EG, Schuetz JD, Gonzalez FJ and Korzekwa KR (1994) O-Demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. Mol Pharmacol 45:352-358.
21. Robertson DR, Waller DG, Renwick AG and George CF (1988) Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol 25:297-305.
22. Schmucker DL, Woodhouse KW, Wang RK, Wynne H, James OF, McManus M and Kremers P (1990) Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 48:365-374.
23. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes invoked in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
24. Sonnichsen DS, Lui Q, Schuetz EG, Schuetz JD, Pappo A and Relling MV (1995) Variability in human CYP450 metabolism of paclitaxel in vitro and in vivo. J Pharmacol Exp Ther 275:566-575.
25. Szefler SJ, Pieroni DR, Gingell RL and Shen DD (1982) Rapid elimination of quinidine in pediatric patients. Pediatrics 70:370-375.
26. Treluyer JM, Jacqz-Aigrain E, Alvarez F and Cresteil T (1991) Expression of CYP2D6 in developing human liver. Eur J Biochem 202:583-588.
27. Vieira I, Sonnier M and Cresteil T (1996) Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur J Biochem 238:476-483.